Animalcare Grp Regulatory News (ANCR)

23 March 2012

Animalcare Group plc

("Animalcare")

Marketing Authorisation for Project Quattro

Animalcare Group plc (AIM: ANCR), a leading supplier of veterinary medicines, announces that Project Quattro, a product from Animalcare's development pipeline, has received Marketing Authorisation from the Veterinary Medicines Directorate.

Receipt of Marketing Authorisation is a prerequisite for placing a new veterinary medicinal product on the market, after routine approvals for product packaging, allowing Animalcare to make final preparations for a full commercial launch.

For commercial reasons the full details of Project Quattro will be given at launch, with first sales expected to take place by the end of the current financial year (30 June 2012).

Stephen Wildridge, CEO of Animalcare Group plc, said: "The continued growth of our licensed veterinary medicines portfolio is an important aspect of our growth strategy. As we announced at our recent Interim Results, the trading in our core business is driven by new product introductions through the year and the news that the development of Project Quattro is advancing as planned is further testament to the delivery of our strategy."

For further information, please contact:

About Animalcare plc - www.animalcaregroup.co.uk

Animalcare Group develops and sells goods and services to veterinary professionals principally for use in companion animals. It operates directly in the UK and through distribution and development partners in key markets in Western Europe.

Its principal product lines are licensed veterinary medicines and companion animal identification products and services.